Andrew M. Green - 11 Jun 2026 Form 4 Insider Report for ARTIVION, INC. (AORT)

Reporting relationship: SVP, Regulatory and Quality
Issuer ticker: AORT
Reported as of: 11 Jun 2026
Net transaction value: -$910,739
SEC form: 4
Accepted by SEC: 15 Jun 2026, 11:28:57 UTC
Prior SEC filing: 08 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Andrew M. Green

Key filing fact

Andrew M. Green filed Form 4 for ARTIVION, INC. (AORT) on 15 Jun 2026.

Key facts

This page summarizes Andrew M. Green's Form 4 filing for ARTIVION, INC. (AORT).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 15 Jun 2026, 11:28.

Change

Previous filing in this sequence was filed on 08 Jun 2026.
Current net transaction value: -$910,739.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001191000 Primary reporting owner

GREEN ANDREW M

Relationship: SVP, Regulatory and Quality
Address: 1655 ROBERTS BLVD., NW, KENNESAW
Signature: /s/ Andrew M. Green
Signature date: 15 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AORT transaction

Common Stock

Options Exercise

Transaction value
Shares: +14,001
Change %: +23%
Price: $18.44^*
Shares after: 74,260
Date: 11 Jun 2026
Ownership: Direct
Footnotes: F1

AORT transaction

Common Stock

Sale

Transaction value: $289,919
Shares: -14,001
Change %: -19%
Price: $20.71
Shares after: 60,259
Date: 11 Jun 2026
Ownership: Direct
Footnotes: F1, F2

AORT transaction

Common Stock

Options Exercise

Transaction value
Shares: +30,000
Change %: +50%
Price: $11.03^*
Shares after: 90,259
Date: 11 Jun 2026
Ownership: Direct
Footnotes: F1

AORT transaction

Common Stock

Sale

Transaction value: $620,820
Shares: -30,000
Change %: -33%
Price: $20.69
Shares after: 60,259
Date: 11 Jun 2026
Ownership: Direct
Footnotes: F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AORT transaction Derivative

Stock Options (Right to buy)

Options Exercise

Transaction value
Shares: -14,001
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 11 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 14,001
Exercise price: $18.44
Footnotes: F1, F4

AORT transaction Derivative

Stock Options (Right to buy)

Options Exercise

Transaction value
Shares: -30,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 11 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 30,000
Exercise price: $11.03
Footnotes: F1, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2026.

Footnote F2

Reflects weighted average price. Range of prices were between $20.25 to $21.02. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F3

Reflects weighted average price. Range of prices were between $20.24 to $21.02. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F4

Stock options vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was February 23, 2023.

Footnote F5

Stock options vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was November 8, 2023.